AUROPHARMA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Aurobindo Pharma Ltd reported sales of ₹9,150 Cr, operating profit of ₹1,880 Cr (OPM 21%) and net profit of ₹1,032 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
AUROPHARMA quarterly results (₹ Cr)
Metric
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
7,796
7,979
8,382
7,868
8,286
8,646
8,853
9,150
YoY Sales growth
8
9
11
4
6
8
6
16
Expenses
6,230
6,401
6,622
6,265
6,608
6,873
7,103
7,271
Operating Profit
1,566
1,578
1,760
1,603
1,678
1,773
1,750
1,880
OPM
20%
20%
21%
20%
20%
21%
20%
21%
Other Income
136
159
135
107
122
123
117
224
Interest
113
118
115
98
95
93
98
102
Depreciation
382
419
444
406
429
465
479
487
Profit before tax
1,207
1,200
1,335
1,207
1,276
1,339
1,291
1,515
Tax
32%
30%
32%
32%
34%
32%
29%
32%
Net Profit
817
846
903
824
848
910
921
1,032
EPS in Rs
14.07
14.56
15.56
14.2
14.61
15.67
15.86
17.95
AUROPHARMA profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
23,455
24,855
29,002
31,724
33,653
34,935
Sales growth
-5
6
17
9
6
9
Expenses
19,060
21,148
23,176
25,164
26,783
27,854
Operating Profit
4,396
3,707
5,826
6,560
6,870
7,081
OPM
19%
15%
20%
21%
20%
20%
Other Income
152
291
366
613
404
586
Interest
49
140
290
457
384
388
Depreciation
1,127
1,245
1,522
1,649
1,778
1,859
Profit before tax
3,373
2,612
4,380
5,066
5,112
5,420
Tax
22%
26%
28%
31%
31%
-
Net Profit
2,647
1,928
3,169
3,484
3,503
3,711
EPS in Rs
45.2
32.9
54.15
60.02
60.34
64.09
Dividend Payout
20%
23%
8%
0%
7%
-
AUROPHARMA balance sheet (₹ Cr)
Metric
Mar 2023
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Equity Capital
59
59
58
-
58
Reserves
26,781
29,784
32,595
-
37,833
Borrowings
5,286
6,648
8,263
-
8,073
Other Liabilities
7,379
8,227
8,566
-
12,232
Total Liabilities
39,505
44,717
49,482
-
58,196
Fixed Assets
11,024
14,493
14,794
-
17,407
CWIP
5,390
3,869
4,900
-
5,214
Investments
543
372
252
-
1,051
Other Assets
22,549
25,983
29,536
-
34,525
Total Assets
39,505
44,717
49,482
-
58,196
AUROPHARMA cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
5,016
2,387
2,435
3,925
5,526
Cash from Investing Activity
-3,211
-3,971
-4,242
-1,866
-2,630
Cash from Financing Activity
-2,969
1,814
800
120
-1,269
Net Cash Flow
-1,164
230
-1,007
2,178
1,628
Free Cash Flow
2,693
-323
-1,067
1,408
2,468
CFO/OP
143%
84%
72%
86%
107%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit